Inhibikase Therapeutics raises $10M as disease treatments show success
February 08, 2023 at 13:00 PM EST
The Atlanta-based pharmaceutical company raised $10 million to develop treatments related to Parkinson’s Disease and chronic myelogenous leukemia.
